Cytomedix Inc. Provides Update On FDA 510(k) Premarket Notification For AutoloGel

ROCKVILLE, Md., Oct. 5, 2006 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) today announced an update on the 510(k) Premarket Notification needed for marketing clearance for the AutoloGel(tm) System that has been filed with the U.S. Food and Drug Administration (FDA).

MORE ON THIS TOPIC